PRODH2
Basic information
Region (hg38): 19:35799988-35813299
Links
Phenotypes
GenCC
Source:
- hydroxyprolinemia (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRODH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 53 | 56 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 54 | 5 | 2 |
Variants in PRODH2
This is a list of pathogenic ClinVar variants found in the PRODH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35800060-C-T | Uncertain significance (Oct 01, 2022) | |||
19-35800073-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
19-35800112-G-A | not specified | Uncertain significance (Sep 22, 2021) | ||
19-35800120-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
19-35800132-C-A | not specified | Uncertain significance (Sep 11, 2024) | ||
19-35800132-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
19-35800141-T-C | not specified | Uncertain significance (Apr 13, 2023) | ||
19-35800145-C-A | not specified | Uncertain significance (May 11, 2022) | ||
19-35800146-C-G | not specified | Uncertain significance (Nov 01, 2022) | ||
19-35800150-C-T | not specified | Uncertain significance (Dec 19, 2023) | ||
19-35800172-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
19-35800187-A-T | not specified | Uncertain significance (Jul 26, 2024) | ||
19-35800214-C-T | not specified | Uncertain significance (May 22, 2024) | ||
19-35802258-A-C | not specified | Uncertain significance (Jan 21, 2025) | ||
19-35802273-C-T | not specified | Uncertain significance (May 15, 2023) | ||
19-35802983-C-A | not specified | Uncertain significance (Jun 10, 2024) | ||
19-35803025-A-G | not specified | Uncertain significance (Aug 19, 2024) | ||
19-35803034-T-C | not specified | Likely benign (Aug 11, 2022) | ||
19-35803037-C-T | not specified | Likely benign (Dec 03, 2024) | ||
19-35803049-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
19-35803070-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
19-35803071-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
19-35803071-G-C | not specified | Uncertain significance (May 13, 2024) | ||
19-35806422-G-A | PRODH2-related disorder | Likely benign (Aug 22, 2019) | ||
19-35806461-T-C | not specified | Uncertain significance (Aug 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRODH2 | protein_coding | protein_coding | ENST00000301175 | 11 | 13312 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.45e-13 | 0.127 | 125441 | 1 | 305 | 125747 | 0.00122 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.118 | 314 | 320 | 0.981 | 0.0000204 | 3348 |
Missense in Polyphen | 85 | 101.71 | 0.83573 | 1064 | ||
Synonymous | 0.205 | 136 | 139 | 0.978 | 0.00000862 | 1178 |
Loss of Function | 0.798 | 22 | 26.4 | 0.832 | 0.00000148 | 269 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000689 | 0.000678 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.00191 | 0.00190 |
Finnish | 0.00620 | 0.00616 |
European (Non-Finnish) | 0.000882 | 0.000871 |
Middle Eastern | 0.00191 | 0.00190 |
South Asian | 0.000269 | 0.000261 |
Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Dehydrogenase that converts trans-4-L-hydroxyproline to delta-1-pyrroline-3-hydroxy-5-carboxylate (Hyp) using ubiquinone- 10 as the terminal electron acceptor. Can also use proline as a substrate but with a very much lower efficiency. Does not react with other diastereomers of Hyp: trans-4-D-hydroxyproline and cis- 4-L-hydroxyproline. Ubiquininone analogs such as menadione, duroquinone and ubiquinone-1 react more efficiently than oxygen as the terminal electron acceptor during catalysis. {ECO:0000269|PubMed:25697095}.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Proline catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;Metabolism;4-hydroxyproline degradation;Glyoxylate metabolism and glycine degradation
(Consensus)
Intolerance Scores
- loftool
- 0.930
- rvis_EVS
- 0.27
- rvis_percentile_EVS
- 70.73
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.219
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prodh2
- Phenotype
Gene ontology
- Biological process
- proline catabolic process;proline catabolic process to glutamate;glyoxylate metabolic process;oxidation-reduction process
- Cellular component
- mitochondrion;mitochondrial inner membrane
- Molecular function
- proline dehydrogenase activity;oxidoreductase activity, acting on the CH-NH group of donors;FAD binding